8-hydroxy-2--deoxyguanosine and Adenocarcinoma--Clear-Cell

8-hydroxy-2--deoxyguanosine has been researched along with Adenocarcinoma--Clear-Cell* in 2 studies

Other Studies

2 other study(ies) available for 8-hydroxy-2--deoxyguanosine and Adenocarcinoma--Clear-Cell

ArticleYear
Immunohistochemical expression of CD44v9 and 8-OHdG in ovarian endometrioma and the benign endometriotic lesions adjacent to clear cell carcinoma.
    The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:11

    Expression of CD44 variant isoforms (CD44v) promotes the synthesis of reduced glutathione and contributes to reactive oxygen species defense through up-regulation of the intracellular antioxidant. The aim of the study was to investigate the expression of CD44v9 and oxidative DNA damage marker, 8-OHdG, in benign ovarian endometrioma (OE) and OE harboring clear cell carcinomas (CCC).. A retrospective study was performed at the Department of Gynecology, Nara Medical University hospital from January 2006 to December 2012. Patients with histologically confirmed benign OE (n = 27) and OE harboring areas of CCC (n = 8) were selected. Tissue samples were immunohistochemically analyzed for the presence of CD44v9 and 8-OHdG using avidin-biotin complex method.. CD44v9 was located on the cell membrane of endometriotic epithelial cells and expressed in 88.9% (24/27) of benign OE tissues. Only 25.0% (2/8) of benign endometriotic lesions adjacent to CCC was found to stain weakly for CD44v9. Percentage of CD44v9 positive cells was 68.5 ± 20.2% (mean ± standard deviation) of benign OE, 16.7 ± 16.5% of CCC endometriotic tissue (P < 0.001). Compared to benign OE, CCC endometriotic tissue showed a significant increase in the proportion of 8-OHdG expression (77.3 ± 22.5% vs 94.9 ± 3.0%, P = 0.049). A significant negative correlation was observed between CD44v9 status and 8-OHdG nuclear expression (r = -0.458, P  =  0.006).. Alterations in CD44v9 and 8-OHdG may be associated with malignant transformation of benign OE.

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenocarcinoma, Clear Cell; Adult; Biomarkers, Tumor; Cell Transformation, Neoplastic; Endometriosis; Epithelial Cells; Female; Humans; Hyaluronan Receptors; Immunohistochemistry; Middle Aged; Ovarian Neoplasms; Ovary; Reactive Oxygen Species; Retrospective Studies

2019
Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.
    Anticancer research, 2011, Volume: 31, Issue:4

    8-Hydroxydeoxyguanosine (8-OHdG) is a marker of oxidative stress in DNA. This study was undertaken to reveal whether serum 8-OHdG could be a prognostic factor in epithelial ovarian carcinoma (EOC).. Preoperative serum 8-OHdG levels were examined by enzyme-linked immunosorbent assay in 84 stage I-IV EOC patients. Immunohistochemical (IHC) 8-OHdG expression was determined in 78 of these patients.. Strong 8-OHdG immunostaining predicted poor survival. High serum 8-OHdG (>140 pg/ml) was associated with poor ovarian cancer-specific survival (p<0.05) in patients with grade 1-2 EOC (p<0.05), but was not observed among the grade 3 patients. High 8-OHdG levels both in the serum and in the tumour tissue was associated with traditional factors of poor prognosis and serous histology.. Both serum and IHC 8-OHdG assessment may serve as prognostic tools in EOC and the role of oxidative stress as a carcinogenic factor in ovarian cancer pathogenesis is also suggested.

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cystadenocarcinoma, Serous; Deoxyguanosine; Endometrial Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Oxidative Stress; Prognosis; Survival Rate

2011